- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03573856
Reducing Diabetes Risk Factors in American Indian Children: Tribal Turning Point (TTP)
November 17, 2022 updated by: University of Colorado, Denver
This study will evaluate a behavioral intervention designed to reduce risk factors for type 2 diabetes in American Indian youth aged 7-10 years.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
The objectives of tis study are to rigorously evaluate the effect of Tribal Turning Point (TTP) on diabetes risk factors in Native youth.
The investigators will enroll up to 360 youth who are aged 7-10 years, overweight/obese (BMI >85th percentile), self-identify as American Indian, and have >1 parent/primary caregiver willing to actively participate in the program.
Within each community, youth will be randomized to the TTP program or a general health and safety control program.
The multi-component TTP intervention is a youth-centered adaptation of the Diabetes Prevention Program designed to reduce diabetes risk factors by improving activity and dietary behaviors.
Informed by the pediatric weight management literature, the 12-month intervention includes 12 active learning group classes, 7 individual youth/parent motivational interviewing counseling sessions, and community-specific resource toolboxes.
In this trial, the investigators will assess the effect of TTP on anthropometric, metabolic, and behavioral risk factors for type 2 diabetes at the end of the intervention (12mo) and after 1 year of follow-up (24mo).
Study Type
Interventional
Enrollment (Actual)
188
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Childrens Hospital Colorado
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 10 years (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- self-identify as American Indian
- BMI >=85th percentile for age and sex
- have at least one parent/primary caregiver (parent) willing to actively participate
Exclusion Criteria:
- diabetes
- any serious youth/parent health concerns that would interfere with participation
- plans to move out of the area during the study period
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Active Living
Three component behavioral intervention consisting of group-based classes, individual motivational interviewing-based sessions, and resource toolbox
|
Participants will be provided with education and support for diet and lifestyle modification related to healthy eating and active living.
|
PLACEBO_COMPARATOR: Health and Safety
One component health and safety program consisting of group classes
|
Participants will be provided with education related to general health and safety topics.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from 0 to 12 months in Body Mass Index (BMI)
Time Frame: 12 months
|
12 months
|
Change from 0 to 12 months in fasting insulin
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from 0 to 12 months in BMI z-score
Time Frame: 12 months
|
12 months
|
Change from 0 to 12 months in waist circumference
Time Frame: 12 months
|
12 months
|
Change from 0 to 12 months in hemoglobin A1c
Time Frame: 12 months
|
12 months
|
Change from 0 to 12 months in fasting glucose
Time Frame: 12 months
|
12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from 0 to 12 months in fruit/vegetable intake
Time Frame: 12 months
|
Proportion consuming 5+ servings of fruits/vegetables daily
|
12 months
|
Change from 0 to 12 months in physical activity
Time Frame: 12 months
|
Proportion engaging in 1+ hour of moderate-vigorous physical activity daily
|
12 months
|
Change from 0 to 12 months in screen time
Time Frame: 12 months
|
Proportion watching 2 hours or less of screen time daily
|
12 months
|
Change from 0 to 12 months in sugary beverage intake
Time Frame: 12 months
|
Proportion consuming 0 servings of sugary beverages daily
|
12 months
|
Participant engagement
Time Frame: 12 months
|
Qualitative factors related to participant engagement
|
12 months
|
Program implementation
Time Frame: 12 months
|
Qualitative factors related to program implementation
|
12 months
|
Potential for sustained delivery
Time Frame: 12 months
|
Qualitative factors related to potential for sustained delivery
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 1, 2018
Primary Completion (ANTICIPATED)
September 1, 2023
Study Completion (ANTICIPATED)
September 1, 2023
Study Registration Dates
First Submitted
May 21, 2018
First Submitted That Met QC Criteria
June 19, 2018
First Posted (ACTUAL)
June 29, 2018
Study Record Updates
Last Update Posted (ACTUAL)
November 21, 2022
Last Update Submitted That Met QC Criteria
November 17, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-1306
- R01DK115434 (NIH)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight/Obesity
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsNot yet recruitingOverweight and Obesity | Overweight, Childhood | Overweight, Infant
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Memorial Sloan Kettering Cancer CenterRecruitingObesity | Overweight | Overweight and Obesity | Obese | Overweight or ObesityUnited States
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
National Taiwan University HospitalCompleted
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
-
University of British ColumbiaTerminatedOverweight and ObesityCanada
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
Clinical Trials on Active Living
-
Centers for Disease Control and PreventionUniversity of North CarolinaCompleted
-
University of MichiganWithdrawnSedentary BehaviorUnited States
-
Northwestern UniversityCompleted
-
University of Southern CaliforniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 1United States
-
University of New MexicoNational Center for Research Resources (NCRR)Terminated
-
University of Southern CaliforniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1United States
-
University of Southern CaliforniaNational Center for Advancing Translational Sciences (NCATS); Los Angeles County...CompletedDiabetes MellitusUnited States
-
University of Texas Southwestern Medical CenterAmerican Cancer Society, Inc.CompletedDepression | Breast Cancer | Physical ActivityUnited States
-
Kowloon Hospital, Hong KongChinese University of Hong Kong; Kwong Wah HospitalCompletedStroke | Foot Drop (Acquired)Hong Kong
-
Athabasca UniversityCompletedDiabetes Mellitus Gestational Previous PregnancyCanada